Genetic susceptibility to lung cancer

Frontiers in Bioscience - Scholar

Volumn 3 S, Issue 4, 2011, Pages 1463-1477

  Sugimura, Haruhiko ^a   Tao, Hong ^a   Suzuki, Masaya ^a   Mori, Hiroki ^a   Tsuboi, Masaru ^a   Matsuura, Shun ^a   Goto, Masanori ^a   Shinmura, Kazuya ^a   Ozawa, Takachika ^b   Tanioka, Fumihiko ^c   Sato, Naomi ^a   Matsushima, Yoshitaka ^a   Kageyama, Shinji ^a   Funai, Kazuhito ^a   Chou, Pei Hsin ^d   Matsuda, Tomonari ^d  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HAMAMATSU MEDICAL CENTER   (Japan)

^c Iwata City Hospital   (Japan)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

Adductome; CYP; DNA adducts; DNA repair; Genomewide association study (GWAS); Lung cancer susceptibility; Review; Single nucleotide polymorphism (SNP); Smoking behavior

Indexed keywords

CYTOCHROME P450 1A1; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; PROTEIN P53; REACTIVE OXYGEN METABOLITE; XERODERMA PIGMENTOSUM GROUP D PROTEIN; XRCC3 PROTEIN; CYTOCHROME P450;

AMINO ACID SUBSTITUTION; ARTICLE; BEHAVIOR GENETICS; CANCER RISK; CANCER SUSCEPTIBILITY; COHORT ANALYSIS; DNA ADDUCT; DNA DAMAGE; DNA FLANKING REGION; DNA REPAIR; DNA REPLICATION; EPIGENETICS; ETHNIC DIFFERENCE; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN GENOME; INDUCED MUTATION; LIFESTYLE; LIPID PEROXIDATION; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG CARCINOGENESIS; LUNG SQUAMOUS CELL CARCINOMA; META ANALYSIS (TOPIC); MUTAGENICITY; NUCLEOPHILICITY; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SMOKING CESSATION PROGRAM; SUBSTANCE ABUSE; TOBACCO DEPENDENCE; XENOBIOTIC METABOLISM; CHEMICALLY INDUCED DISORDER; EXPOSURE; GENETIC EPIGENESIS; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; LUNG TUMOR; METHODOLOGY; ONCOGENE; REVIEW;

CYTOCHROME P-450 ENZYME SYSTEM; EPIGENESIS, GENETIC; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GLUTATHIONE TRANSFERASE; HUMANS; INHALATION EXPOSURE; LUNG NEOPLASMS; ONCOGENES; POLYMORPHISM, GENETIC; SMOKING;

EID: 80053096262     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: 10.2741/s237     Document Type: Article

References (113)

1. J. Higginson and O. M. Jensen: Epidemiological review of lung cancer in man. IARC Sci Publ(16), 169-89 (1977)
2. R. E. Kouri, L. H. Billups, T. H. Rude, C. E. Whitmire, B. Sass and C. J. Henry: Correlation of inducibility of aryl hydrocarbon hydroxylase with susceptibility to 3- methylcholanthrene-induced lung cancers. Cancer Lett, 9(4), 277-84 (1980)
3. R. Ayesh, J. R. Idle, J. C. Ritchie, M. J. Crothers and M. R. Hetzel: Metabolic oxidation phenotypes as markers for susceptibility to lung cancer. Nature, 312(5990), 169-70 (1984)
4. F. P. Perera and I. B. Weinstein: Molecular epidemiology and carcinogen-DNA adduct detection: new approaches to studies of human cancer causation. J Chronic Dis, 35(7), 581-600 (1982)
5. C. C. Harris, A. Weston, J. C. Willey, G. E. Trivers and D. L. Mann: Biochemical and molecular epidemiology of human cancer: indicators of carcinogen exposure, DNA damage, and genetic predisposition. Environ Health Perspect, 75, 109-19 (1987)
6. H. Sugimura, A. Weston, N. E. Caporaso, P. G. Shields, E. D. Bowman, R. A. Metcalf and C. C. Harris: Biochemical and molecular epidemiology of cancer. Biomed Environ Sci, 4(1-2), 73-92 (1991)
7. N. E. Caporaso and M. T. Landi: Molecular epidemiology: a new perspective for the study of toxic exposures in man. A consideration of the influence of genetic susceptibility factors on risk in different lung cancer histologies. Med Lav, 85(1), 68-77 (1994)
8. K. Kawajiri, K. Nakachi, K. Imai, A. Yoshii, N. Shinoda and J. Watanabe: Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene. FEBS Lett, 263(1), 131-3 (1990)
9. K. Kawajiri, H. Eguchi, K. Nakachi, T. Sekiya and M. Yamamoto: Association of CYP1A1 germ line polymorphisms with mutations of the p53 gene in lung cancer. Cancer Res, 56(1), 72-6 (1996)
10. H. Sugimura, K. Wakai, K. Genka, K. Nagura, H. Igarashi, K. Nagayama, A. Ohkawa, S. Baba, B. J. Morris, S. Tsugane, Y. Ohno, C. Gao, Z. Li, T. Takezaki, K. Tajima and T. Iwamasa: Association of Ile462Val (Exon 7) polymorphism of cytochrome P450 IA1 with lung cancer in the Asian population: further evidence from a case-control study in Okinawa. C ancer Epidemiol Biomarkers Prev, 7(5), 413-7 (1998)
11. G. S. Hamada, H. Sugimura, I. Suzuki, K. Nagura, E. Kiyokawa, T. Iwase, M. Tanaka, T. Takahashi, S. Watanabe, I. Kino and et al.: The heme-binding region polymorphism of cytochrome P450IA1 (CypIA1), rather than the RsaI polymorphism of IIE1 (CypIIE1), is associated with lung cancer in Rio de Janeiro. Cancer Epidemiol Biomarkers Prev, 4(1), 63-7 (1995)
12. K. Nakachi, K. Imai, S. Hayashi, J. Watanabe and K. Kawajiri: Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res, 51(19), 5177-80 (1991)
13. A. Hirvonen, K. Husgafvel-Pursiainen, A. Karjalainen, S. Anttila and H. Vainio: Point-mutational MspI and Ile- Val polymorphisms closely linked in the CYP1A1 gene: lack of association with susceptibility to lung cancer in a Finnish study population. Cancer Epidemiol Biomarkers Prev, 1(6), 485-9 (1992)
14. A. K. Alexandrie, M. I. Sundberg, J. Seidegard, G. Tornling and A. Rannug: Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age at onset, gender and histological cancer types. Carcinogenesis, 15(9), 1785-90 (1994)
15. P. Vineis, F. Veglia, S. Benhamou, D. Butkiewicz, I. Cascorbi, M. L. Clapper, V. Dolzan, A. Haugen, A. Hirvonen, M. Ingelman-Sundberg, M. Kihara, C. Kiyohara, P. Kremers, L. Le Marchand, S. Ohshima, R. Pastorelli, A. Rannug, M. Romkes, B. Schoket, P. Shields, R. C. Strange, I. Stucker, H. Sugimura, S. Garte, L. Gaspari and E. Taioli: CYP1A1 T3801 C polymorphism and lung cancer: a pooled analysis of 2451 cases and 3358 controls. Int J Cancer, 104(5), 650-7 (2003)
16. F. Uematsu, H. Kikuchi, M. Motomiya, T. Abe, I. Sagami, T. Ohmachi, A. Wakui, R. Kanamaru and M. Watanabe: Association between restriction fragment length polymorphism of the human cytochrome P450IIE1 gene and susceptibility to lung cancer. Jpn J Cancer Res, 82(3), 254-6 (1991)
17. S. Ikawa, F. Uematsu, K. Watanabe, T. Kimpara, M. Osada, A. Hossain, I. Sagami, H. Kikuchi and M. Watanabe: Assessment of cancer susceptibility in humans by use of genetic polymorphisms in carcinogen metabolism. Pharmacogenetics, 5 Spec No, S154-60 (1995)
18. S. J. London, A. K. Daly, J. Cooper, C. L. Carpenter, W. C. Navidi, L. Ding and J. R. Idle: Lung cancer risk in relation to the CYP2E1 Rsa I genetic polymorphism among African-Americans and Caucasians in Los Angeles County. Pharmacogenetics, 6(2), 151-8 (1996)
19. L. Le Marchand, L. Sivaraman, L. Pierce, A. Seifried, A. Lum, L. R. Wilkens and A. F. Lau: Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens. Cancer Res, 58(21), 4858-63 (1998)
20. L. L. Marchand, G. R. Wilkinson and L. R. Wilkens: Genetic and dietary predictors of CYP2E1 activity: a phenotyping study in Hawaii Japanese using chlorzoxazone. Cancer Epidemiol Biomarkers Prev, 8(6), 495-500 (1999)
21. C. M. Gao, T. Takezaki, J. Z. Wu, M. B. Chen, Y. T. Liu, J. H. Ding, H. Sugimura, J. Cao, N. Hamajima and K. Tajima: CYP2E1 Rsa I polymorphism impacts on risk of colorectal cancer association with smoking and alcohol drinking. World J Gastroenterol, 13(43), 5725-30 (2007)
22. S. Kato, E. D. Bowman, A. M. Harrington, B. Blomeke and P. G. Shields: Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo. J Natl Cancer Inst, 87(12), 902-7 (1995)
23. T. Kamataki, K. Fujita, K. Nakayama, Y. Yamazaki, M. Miyamoto and N. Ariyoshi: Role of human cytochrome P450 ( CYP) in the metabolic activation of nitrosamine derivatives: application of genetically engineered Salmonella expressing human CYP. Drug Metab Rev, 34(3), 667-76 (2002)
24. M. Miyamoto, Y. Umetsu, H. Dosaka-Akita, Y. Sawamura, J. Yokota, H. Kunitoh, N. Nemoto, K. Sato, N. Ariyoshi and T. Kamataki: CYP2A6 gene deletion reduces susceptibility to lung cancer. Biochem Biophys Res Commun, 261(3), 658-60 (1999)
25. M. Fujieda, H. Yamazaki, T. Saito, K. Kiyotani, M. A. Gyamfi, M. Sakurai, H. Dosaka-Akita, Y. Sawamura, J. Yokota, H. Kunitoh and T. Kamataki: Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokers. Carcinogenesis, 25(12), 2451-8 (2004)
26. Y. Mitani, A. Lezhava, A. Sakurai, A. Horikawa, M. Nagakura, Y. Hayashizaki and T. Ishikawa: Rapid and cost-effective SNP detection method: application of SmartAmp2 to pharmacogenomics research. Pharmacogenomics, 10(7), 1187-97 (2009)
27. Y. Mitani, A. Lezhava, Y. Kawai, T. Kikuchi, A. Oguchi-Katayama, Y. Kogo, M. Itoh, T. Miyagi, H. Takakura, K. Hoshi, C. Kato, T. Arakawa, K. Shibata, K. Fukui, R. Masui, S. Kuramitsu, K. Kiyotani, A. Chalk, K. Tsunekawa, M. Murakami, T. Kamataki, T. Oka, H. Shimada, P. E. Cizdziel and Y. Hayashizaki: Rapid SNP diagnostics using asymmetric isothermal amplification and a new mismatch-suppression technology. Nat Methods, 4(3), 257-62 (2007)
28. S. Zhong, A. F. Howie, B. Ketterer, J. Taylor, J. D. Hayes, G. J. Beckett, C. G. Wathen, C. R. Wolf and N. K. Spurr: Glutathione S-transferase mu locus: use of genotyping and phenotyping assays to assess association with lung cancer susceptibility. Carcinogenesis, 12(9), 1533-7 (1991)
29. D. A. Bell, C. L. Thompson, J. Taylor, C. R. Miller, F. Perera, L. L. Hsieh and G. W. Lucier: Genetic monitoring of human polymorphic cancer susceptibility genes by polymerase chain reaction: application to glutathione transferase mu. Environ Health Perspect, 98, 113-7 (1992)
30. A. Hirvonen, K. Husgafvel-Pursiainen, S. Anttila and H. Vainio: The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung. Carcinogenesis, 14(7), 1479-81 (1993)
31. R. Redon, S. Ishikawa, K. R. Fitch, L. Feuk, G. H. Perry, T. D. Andrews, H. Fiegler, M. H. Shapero, A. R. Carson, W. Chen, E. K. Cho, S. Dallaire, J. L. Freeman, J. R. Gonzalez, M. Gratacos, J. Huang, D. Kalaitzopoulos, D. Komura, J. R. MacDonald , C. R. Marshall, R. Mei, L. Montgomery, K. Nishimura, K. Okamura, F. Shen, M. J. Somerville, J. Tchinda, A. Valsesia, C. Woodwark, F. Yang, J. Zhang, T. Zerjal, L. Armengol, D. F. Conrad, X. Estivill, C. Tyler-Smith, N. P. Carter, H. Aburatani, C. Lee, K. W. Jones, S. W. Scherer and M. E. Hurles: Global variation in copy number in the human genome. Nature, 444(7118), 444-54 (2006)
32. K. Nakachi, K. Imai, S. Hayashi and K. Kawajiri: Polymorphisms of the CYP1A1 and glutathione Stransferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res, 53(13), 2994-9 (1993)
33. A. K. Alexandrie, F. Nyberg, M. Warholm and A. Rannug: Influence of CYP1A1, GSTM1, GSTT1, and NQO1 genotypes and cumulative smoking dose on lung cancer risk in a Swedish population. Cancer Epidemiol Biomarkers Prev, 13(6), 908-14 (2004)
34. T. Lindahl and R. D. Wood: Quality control by DNA repair. Science, 286(5446), 1897-905 (1999) doi:8045 [pii]
35. R. D. Wood, M. Mitchell, J. Sgouros and T. Lindahl: Human DNA repair genes. Science, 291(5507), 1284-9 (2001)
36. O. D. Scharer: Hot topics in DNA repair: the molecular basis for different disease states caused by mutations in TFIIH and XPG. DNA Repair (Amst), 7(2), 339-44 (2008)
37. K. Sugasawa: Regulation of damage recognition in mammalian global genomic nucleotide excision repair. Mutat Res, 685(1-2), 29-37 (2010)
38. K. Subba Rao: Mechanisms of disease: DNA repair defects and neurological disease. Nat Clin Pract Neurol, 3(3), 162-72 (2007)
39. H. Aburatani, Y. Hippo, T. Ishida, R. Takashima, C. Matsuba, T. Kodama, M. Takao, A. Yasui, K. Yamamoto and M. Asano: Cloning and characterization of mammalian 8-hydroxyguanine-specific DNA glycosylase/apurinic, apyrimidinic lyase, a functional mutM homologue. Cancer Res, 57(11), 2151-6 (1997)
40. J. P. Radicella, C. Dherin, C. Desmaze, M. S. Fox and S. Boiteux: Cloning and characterization of hOGG1, a human homolog of the OGG1 gene of Saccharomyces cerevisiae. Proc Natl Acad Sci U S A, 94(15), 8010-5 (1997)
41. T. A. Rosenquist, D. O. Zharkov and A. P. Grollman: Cloning and characterization of a mammalian 8- oxoguanine DNA glycosylase. Proc Natl Acad Sci U S A, 94(14), 7429-34 (1997)
42. K. Shinmura, H. Kasai, A. Sasaki, H. Sugimura and J. Yokota: 8-hydroxyguanine (7,8-dihydro-8-oxoguanine) DNA glycosylase and AP lyase activities of hOGG1 protein and their substrate specificity. Mutat Res, 385(1), 75-82 (1997)
43. T. Kohno, K. Shinmura, M. Tosaka, M. Tani, S. R. Kim, H. Sugimura, T. Nohmi, H. Kasai and J. Yokota: Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8- hydroxyguanine in damaged DNA. Oncogene, 16(25), 3219-25 (1998)
44. H. Sugimura, T. Kohno, K. Wakai, K. Nagura, K. Genka, H. Igarashi, B. J. Morris, S. Baba, Y. Ohno, C. Gao, Z. Li, J. Wang, T. Takezaki, K. Tajima, T. Varga, T. Sawaguchi, J. K. Lum, J. J. Martinson, S. Tsugane, T. Iwamasa, K. Shinmura and J. Yokota: hOGG1 Ser326Cys polymorphism and lung cancer susceptibility. Cancer Epidemiol Biomarkers Prev, 8(8), 669-74 (1999)
45. H. Li, X. Hao, W. Zhang, Q. Wei and K. Chen: The hOGG1 Ser326Cys polymorphism and lung cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev, 17(7), 1739-45 (2008)
46. R. J. Hung, P. Brennan, F. Canzian, N. Szeszenia- Dabrowska, D. Zaridze, J. Lissowska, P. Rudnai, E. Fabianova, D. Mates, L. Foretova, V. Janout, V. Bencko, A. Chabrier, S. Borel, J. Hall and P. Boffetta: Large-scale investigation of base excision repair genetic polymorphisms and lung cancer risk in a multicenter study. J Natl Cancer Inst, 97(8), 567-76 (2005)
47. R. J. Hung, D. C. Christiani, A. Risch, O. Popanda, A. Haugen, S. Zienolddiny, S. Benhamou, C. Bouchardy, Q. Lan, M. R. Spitz, H. E. Wichmann, L. LeMarchand, P. Vineis, G. Matullo, C. Kiyohara, Z. F. Zhang, B. Peze shki, C. Harris, L. Mechanic, A. Seow, D. P. Ng, N. Szeszenia- Dabrowska, D. Zaridze, J. Lissowska, P. Rudnai, E. Fabianova, D. Mates, L. Foretova, V. Janout, V. Bencko, N. Caporaso, C. Chen, E. J. Duell, G. Goodman, J. K. Field, R. S. Houlston, Y. C. Hong, M. T. Landi, P. Lazarus, J. Muscat, J. McLaughlin, A. G. Schwartz, H. Shen, I. Stucker, K. Tajima, K. Matsuo, M. Thun, P. Yang, J. Wiencke, A. S. Andrew, S. Monnier, P. Boffetta and P. Brennan: International Lung Cancer Consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways. Cancer Epidemiol Biomarkers Prev, 17(11), 3081-9 (2008)
48. H. Ito, N. Hamajima, T. Takezaki, K. Matsuo, K. Tajima, S. Hatooka, T. Mitsudomi, M. Suyama, S. Sato and R. Ueda: A limited association of OGG1 Ser326Cys polymorphism for adenocarcinoma of the lung. J Epidemiol, 12(3), 258-65 (2002)
49. T. Kohno, H. Kunitoh, K. Toyama, S. Yamamoto, A. Kuchiba, D. Saito, N. Yanagitani, S. Ishihara, R. Saito and J. Yokota: Association of the OGG1-Ser326Cys polymorphism with lung adenocarcinoma risk. Cancer Sci, 97(8), 724-8 (2006)
50. T. Okasaka, K. Matsuo, T. Suzuki, H. Ito, S. Hosono, T. Kawase, M. Watanabe, Y. Yatabe, T. Hida, T. Mitsudomi, H. Tanaka, K. Yokoi and K. Tajima: hOGG1 Ser326Cys polymorphism and risk of lung cancer by histological type. J Hum Genet, 54(12), 739-45 (2009)
51. J. W. Hill and M. K. Evans: Dimerization and opposite base-dependent catalytic impairment of polymorphic S326C OGG1 glycosylase. Nucleic Acids Res, 34(5), 1620-32 (2006)
52. R. M. Lunn, K. J. Helzlsouer, R. Parshad, D. M. Umbach, E. L. Harris, K. K. Sanford and D. A. Bell: XPD polymorphisms: effects on DNA repair proficiency. Carcinogenesis, 21(4), 551-5 (2000)
53. G. L. David-Beabes, R. M. Lunn and S. J. London: No association between the XPD (Lys751G1n) polymorphism or the XRCC3 (Thr241Met) polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev, 10(8), 911-2 (2001)
54. S. Chen, D. Tang, K. Xue, L. Xu, G. Ma, Y. Hsu and S. S. Cho: DNA repair gene XRCC1 and XPD polymorphisms and risk of lung cancer in a Chinese population. Carcinogenesis, 23(8), 1321-5 (2002)
55. G. Liang, D. Xing, X. Miao, W. Tan, C. Yu, W. Lu and D. Lin: Sequence variations in the DNA repair gene XPD and risk of lung cancer in a Chinese population. Int J Cancer, 105(5), 669-73 (2003)
56. D. Xing, W. Tan, Q. Wei and D. Lin: Polymorphisms of the DNA repair gene XPD and risk of lung cancer in a Chinese population. Lung Cancer, 38(2), 123-9 (2002)
57. M. R. Spitz, X. Wu, Y. Wang, L. E. Wang, S. Shete, C. I. Amos, Z. Guo, L. Lei, H. Mohrenweiser and Q. Wei: Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res, 61(4), 1354-7 (2001)
58. S. Benhamou and A. Sarasin: ERCC2 /XPD gene polymorphisms and lung cancer: a HuGE review. Am J Epidemiol, 161(1), 1-14 (2005)
59. G. Francisco, P. R. Menezes, J. Eluf-Neto and R. Chammas: Arg72Pro TP53 polymorphism and cancer susceptibility: A comprehensive meta-analysis of 302 casecontrol studies. Int J Cancer (2010)
60. Y. Li, L. X. Qiu, X. K. Shen, X. J. Lv, X. P. Qian and Y. Song: A meta -analysis of TP53 codon 72 polymorphism and lung cancer risk: evidence from 15,857 subjects. Lung Cancer, 66(1), 15-21 (2009)
61. E. Tsuchiya, R. Furuta, N. Wada, K. Nakagawa, Y. Ishikawa, B. Kawabuchi, Y. Nakamura and H. Sugano: High K-ras mutation rates in goblet-cell-type adenocarcinomas of the lungs. J Cancer Res Clin Oncol, 121(9-10), 577-81 (1995)
62. L. Lin, M. F. Festing, T. R. Devereux, K. A. Crist, S. C. Christiansen, Y. Wang, A. Yang, K. Svenson, B. Paigen, A. M. Malkinson and M. You: Additional evidence that the Kras protooncogene is a candidate for the major mouse pulmonary adenoma susceptibility (Pas-1) gene. Exp Lung Res, 24(4), 481-97 (1998)
63. J. P. Koivunen, J. Kim, J. Lee, A. M. Rogers, J. O. Park, X. Zhao, K. Naoki, I. Okamoto, K. Nakagawa, B. Y. Yeap, M. Meyerson, K. K. Wong, W. G. Richards, D. J. Sugarbaker, B. E. Johnson and P. A. Janne: Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients. Br J Cancer, 99(2), 245-52 (2008)
64. M. F. Paz, S. Avila, M. F. Fraga, M. Pollan, G. Capella, M. A. Peinado, M. Sanchez-Cespedes, J. G. Herman and M. Esteller: Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors. Cancer Res, 62(15), 4519-24 (2002)
65. L. Makowski and D. N. Hayes: Role of LKB1 in lung cancer development. Br J Cancer, 99(5), 683-8 (2008)
66. J. E. Cropley, D. I. Martin and C. M. Suter: Germline epimutation in humans. Pharmacogenomics, 9(12), 1861-8 (2008)
67. D. Miki, M. Kubo, A. Takahashi, K. A. Yoon, J. Kim, G. K. Lee, J. I. Zo, J. S. Lee, N. Hosono, T. Morizono, T. Tsunoda, N. Kamatani, K. Chayama, T. Takahashi, J. Inazawa, Y. N akamura and Y. Daigo: Variation in TP63 is associated with lung adenocarcinoma susceptibility in Japanese and Korean populations. Nat Genet, 42(10), 893-6 (2010)
68. M. Spinola, V. P. Leoni, A. Galvan, E. Korsching, B. Conti, U. Pastorino, F. Ravagnani, A. Columbano, V. Skaug, A. Haugen and T. A. Dragani: Genome-wide single nucleotide polymorphism analysis of lung cancer risk detects the KLF6 gene. Cancer Lett, 251(2), 311-6 (2007)
69. C. I. Amos, X. Wu, P. Broderick, I. P. Gorlov, J. Gu, T. Eisen, Q. Dong, Q. Zhang, X. Gu, J. Vijayakrishnan, K. Sullivan, A. Matakidou, Y. Wang, G. Mills, K. Doheny, Y. Y. Tsai, W. V. Chen, S. Shete, M. R. Spitz and R. S. Houlston: Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet, 40(5), 616-22 (2008)
70. R. J. Hung, J. D. McKay, V. Gaborieau, P. Boffetta, M. Hashibe, D. Zaridze, A. Mukeria, N. Szeszenia-Dabrowska, J. Lissowska, P. Rudnai, E. Fabianova, D. Mates, V. Bencko, L. Foretova, V. Janout, C. Chen, G. Goodman, J. K. Field, T. Liloglou, G. Xinarianos, A. Cassidy, J. McLaughlin, G. Liu, S. Narod, H. E. Krokan, F. Skorpen, M. B. Elve stad, K. Hveem, L. Vatten, J. Linseisen, F. Clavel-Chapelon, P. Vineis, H. B. Bueno-de-Mesquita, E. Lund, C. Martinez, S. Bingham, T. Rasmuson, P. Hainaut, E. Riboli, W. Ahrens, S. Benhamou, P. L agiou, D. Trichopoulos, I. Holcatova, F. Merletti, K. Kjaerheim, A. Agudo, G. Macfarlane, R. Talamini, L. Simonato, R. Lowry, D. I. Conway, A. Znaor, C. Healy, D. Zelenika, A. Boland, M. Delepine, M. Foglio, D. Lechner, F. Matsuda, H. Blanche, I. Gut, S. Heath, M. Lathrop and P. Brennan: A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature, 452(7187), 633-7 (2008)
71. G. Lettre, A. U. Jackson, C. Gieger, F. R. Schumacher, S. I. Berndt, S. Sanna, S. Eyheramendy, B. F. Voight, J. L. Butler, C. Guiducci, T. Illig, R. Hackett, I. M. Heid, K. B. Jacobs, V. Lyssenko, M. Uda, M. Boehnke, S. J. Chanock, L. C. Groop, F. B. Hu, B. Isomaa, P. Kraft, L. Peltonen, V. Salomaa, D. Schlessinger, D. J. Hunter, R. B. Hayes, G. R. Abecasis, H. E. Wichmann, K. L. Mohlke and J. N. Hirschhorn: Identification of ten loci associated with height highlights new biological pathways in human growth. Nat Genet, 40(5), 584-91 (2008)
72. T. E. Thorgeirsson, F. Geller, P. Sulem, T. Rafnar, A. Wiste, K. P. Magnusson, A. Manolescu, G. Thorleifsson, H. Stefansson, A. Ingason, S. N. Stacey, J. T. Bergthorsson, S. Thorlacius, J. Gudmundsson, T. Jonsson, M. Jakobsdottir, J. Saemundsdottir, O. Olafsdottir, L. J. Gudmundsson, G. Bjornsdottir, K. Kristjansson, H. Skuladottir, H. J. Isaksson, T. Gudbjartsson, G. T. Jones, T. Mueller , A. Gottsater, A. Flex, K. K. Aben, F. de Vegt, P. F. Mulders, D. Isla, M. J. Vidal, L. Asin, B. Saez, L. Murillo, T. Blondal, H. Kolbeinsson, J. G. Stefansson, I. Hansdottir, V. Runarsdottir, R. Pola, B. Lindblad, A. M. van Rij, B. Dieplinger, M. Haltmayer, J. I. Mayordomo, L. A. Kiemeney, S. E. Matthiasson, H. Oskarsson, T. Tyrfingsson, D. F. Gudbjartsson, J. R. Gulcher, S. Jonsson, U. Thorsteinsdottir, A. Kong and K. Stefansson: A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature, 452(7187), 638-42 (2008)
73. J. D. McKay, R. J. Hung, V. Gaborieau, P. Boffetta, A. Chabrier, G. Byrnes, D. Zaridze, A. Mukeria, N. Szeszenia- Dabrowska, J. Lissowska, P. Rudnai, E. Fabianova, D. Mates, V. Bencko, L. Foretova, V. Janout, J. McLaughlin, F. Shepherd, A. Montpetit, S. Narod, H. E. Kro kan, F. Skorpen, M. B. Elvestad, L. Vatten, I. Njolstad, T. Axelsson, C. Chen, G. Goodman, M. Barnett, M. M. Loomis, J. Lubinski, J. Matyjasik, M. Lener, D. Oszutowska, J. Field, T. Liloglou, G. Xinarianos, A. Cassidy, P. Vineis, F. Clavel-Chapelon, D. Pal li, R. Tumino, V. Krogh, S. Panico, C. A. Gonzalez, J. Ramon Quiros, C. Martinez, C. Navarro, E. Ardanaz, N. Larranaga, K. T. Kham, T. Key, H. B. Bueno-de- Mesquita, P. H. Peeters, A. Trichopoulou, J. Linseisen, H. Boeing, G. Hallmans, K. Overvad, A. Tjonn eland, M. Kumle, E. Riboli, D. Zelenika, A. Boland, M. Delepine, M. Foglio, D. Lechner, F. Matsuda, H. Blanche, I. Gut, S. Heath, M. Lathrop and P. Brennan: Lung cancer susceptibility locus at 5p15.33. Nat Genet, 40(12), 1404-6 (2008)
74. Y. Wang, P. Broderick, E. Webb, X. Wu, J. Vijayakrishnan, A. Matakidou, M. Qureshi, Q. Dong, X. Gu, W. V. Chen, M. R. Spitz, T. Eisen, C. I. Amos and R. S. Houlston: Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat Genet, 40(12), 1407-9 (2008)
75. P. Liu, H. G. Vikis, D. Wang, Y. Lu, Y. Wang, A. G. Schwartz, S. M. Pinney, P. Yang, M. de Andrade, G. M. Petersen, J. S. Wiest, P. R. Fain, A. Gazdar, C. Gaba, H. Rothschild, D. Mandal, T. Coons, J. Lee, E. Kupert, D. Seminara, J. Minna, J. E. Bailey-Wilson, X. Wu, M. R. Spitz, T. Eisen, R. S. Houlston, C. I. Amos, M. W. Anderson and M. You: Familial aggregation of common sequence variants on 15q24-25.1 in lung cancer. J Natl Cancer Inst, 100(18), 1326-30 (2008)
76. M. R. Spitz, C. I. Amos, Q. Dong, J. Lin and X. Wu: The CHRNA5-A3 region on chromosome 15q24-25.1 is a risk factor both for nicotine dependence and for lung cancer. J Natl Cancer Inst, 100(21), 1552-6 (2008)
77. C. I. Amos, I. P. Gorlov, Q. Dong, X. Wu, H. Zhang, E. Y. Lu, P. Scheet, A. J. Greisinger, G. B. Mills and M. R. Spitz: Nicotinic acetylcholine receptor region on chromosome 15q25 and lung cancer risk among African Americans: a case-control study. J Natl Cancer Inst, 102(15), 1199-205 (2010)
78. C. Wu, Z. Hu, D. Yu, L. Huang, G. Jin, J. Liang, H. Guo, W. Tan, M. Zhang, J. Qian, D. Lu, T. Wu, D. Lin and H. Shen: Genetic variants on chromosome 15q25 associated with lung cancer risk in Chinese populations. Cancer Res, 69(12), 5065-72 (2009)
79. K. Shiraishi, T. Kohno, H. Kunitoh, S. Watanabe, K. Goto, Y. Nishiwaki, Y. Shimada, H. Hirose, I. Saito, A. Kuchiba, S. Yamamoto and J. Yokota: Contribution of nicotine acetylcholine receptor polymorphisms to lung cancer risk in a smoking-independent manner in the Japanese. Carcinogenesis, 30(1), 65-70 (2009)
80. P. Broderick, Y. Wang, J. Vijayakrishnan, A. Matakidou, M. R. Spitz, T. Eisen, C. I. Amos and R. S. Houlston: Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study. Cancer Res, 69(16), 6633-41 (2009)
81. C. C. Chung, W. C. Magalhaes, J. Gonzalez-Bosquet and S. J. Chanock: Genome-wide association studies in cancer-current and future directions. Carcinogenesis, 31(1), 111-20 (2010)
82. J. Subramanian and R. Govindan: Lung cancer in never smokers: a review. J Clin Oncol, 25(5), 561-70 (2007)
83. S. Sun, J. H. Schiller and A. F. Gazdar: Lung cancer in never smokers-a different disease. Nat Rev Cancer, 7(10), 778-90 (2007)
84. G. K. Tokuhata and A. M. Lilienfeld: Familial aggregation of lung cancer in humans. J Natl Cancer Inst, 30, 289-312 (1963)
85. S. Avenevoli and K. R. Merikangas: Familial influences on adolescent smoking. Addiction, 98 Suppl 1, 1-20 (2003)
86. J. Lorenzo Bermejo and K. Hemminki: Familial lung cancer and aggregation of smoking habits: a simulation of the effect of shared environmental factors on the familial risk of cancer. Cancer Epidemiol Biomarkers Prev, 14(7), 1738-40 (2005)
87. K. C. Wilhelmsen and C. Ehlers: Heritability of substance dependence in a native American population. Psychiatr Genet, 15(2), 101-7 (2005)
88. M. A. Rossing: Genetic influences on smoking: candidate genes. Environ Health Perspect, 106(5), 231-8 (1998)
89. K. Blum, E. R. Braverman, J. M. Holder, J. F. Lubar, V. J. Monastra, D. Miller, J. O. Lubar, T. J. Chen and D. E. Comings: Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors. J Psychoactive Drugs, 32 Suppl, iiv, 1-112 (2000)
90. R. A. Schnoll, T. A. Johnson and C. Lerman: Genetics and smoking behavior. Curr Psychiatry Rep, 9(5), 349-57 (2007)
91. E. L. Goode, M. D. Badzioch, H. Kim, F. Gagnon, L. S. Rozek, K. L. Edwards and G. P. Jarvik: Multiple genomewide analyses of smoking behavior in the Framingham Heart Study. BMC Genet, 4 Suppl 1, S102 (2003)
92. S. F. Saccone, M. L. Pergadia, A. Loukola, U. Broms, G. W. Montgomery, J. C. Wang, A. Agrawal, D. M. Dick, A. C. Heath, A. A. Todorov, H. Maunu, K. Heikkila, K. I. Morley, J. P. Rice, R. D. Todd, J. Kaprio, L. Peltonen, N. G. Martin, A. M. Goate and P. A. Madden: Genetic linkage to chromosome 22q12 for a heavy-smoking quantitative trait in two independent samples. Am J Hum Genet, 80(5), 856-66 (2007)
93. L. J. Bierut, P. A. Madden, N. Breslau, E. O. Johnson, D. Hatsukami, O. F. Pomerleau, G. E. Swan, J. Rutter, S. Bertelsen, L. Fox, D. Fugman, A. M. Goate, A. L. Hinrichs, K. Konvicka, N. G. Martin, G. W. Montgomery, N. L. Saccone, S. F. Saccone, J. C. Wang, G. A. Chase, J. P. Rice and D. G. Ballinger: Novel genes identified in a highdensity genome wide association study for nicotine dependence. Hum Mol Genet, 16(1), 24-35 (2007)
94. M. D. Li and M. Burmeister: New insights into the genetics of addiction. Nat Rev Genet, 10(4), 225-31 (2009)
95. K. O. Fagerstrom: Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav, 3(3-4), 235-41 (1978)
96. N. Kawakami, N. Takatsuka, S. Inaba and H. Shimizu: Development of a screening questionnaire for tobacco/nicotine dependence according to ICD-10, DSMIII- R, and DSM-IV. Addict Behav, 24(2), 155-66 (1999)
97. N. Sato, S. Kageyama, R. Chen, M. Suzuki, H. Mori, F. Tanioka, H. Yamada, T. Kamo, H. Tao, K. Shinmura, A. Nozawa and H. Sugimura: Association between neuropeptide Y receptor 2 polymorphism and the smoking behavior of elderly Japanese. J Hum Genet (2010)
98. N. Sato, S. Kageyama, R. Chen, M. Suzuki, F. Tanioka, T. Kamo, K. Shinmura, A. Nozawa and H. Sugimura: Association between neurexin 1 (NRXN1) polymorphisms and the smoking behavior of elderly Japanese. Psychiatr Genet, 20(3), 135-6 (2010)
99. Consortium, tobacco and genetics: Genome-wide metaanalyses identify multiple loci associated with smoking behavior. Nat Genet, 42(5), 441-7 (2010)
100. J. Z. Liu, F. Tozzi, D. M. Waterworth, S. G. Pillai, P. Muglia, L. Middleton, W. Berrettini, C. W. Knouff, X. Yuan, G. Waeber, P. Vollenweider, M. Preisig, N. J. Wareham, J. H. Zhao, R. J. Loos, I. Barroso, K. T. Khaw, S. Grundy, P. Barter, R. Mahley, A. Kesaniemi, R. McPherson, J. B. Vincent, J. Strauss, J. L. Kennedy, A. Farmer, P. McGuffin, R. Day, K. Matthews, P. Bakke , A. Gulsvik, S. Lucae, M. Ising, T. Brueckl, S. Horstmann, H. E. Wichmann, R. Rawal, N. Dahmen, C. Lamina, O. Polasek, L. Zgaga, J. Huffman, S. Campbell, J. Kooner, J. C. Chambers, M. S. Burn ett, J. M. Devaney, A. D. Pichard, K. M. Kent, L. Satler, J. M. Lindsay, R. Waksman, S. Epstein, J. F. Wilson, S. H. Wild, H. Campbell, V. Vitart, M. P. Reilly, M. Li, L. Qu, R. Wilensky, W. M atthai, H. H. Hakonarson, D. J. Rader, A. Franke, M. Wittig, A. Schafer, M. Uda, A. Terracciano, X. Xiao, F. Busonero, P. Scheet, D. Schlessinger, D. St Clair, D. Rujescu, G. R. Abecasis, H. J. G rabe, A. Teumer, H. Volzke, A. Petersmann, U. John, I. Rudan, C. Hayward, A. F. Wright, I. Kolcic, B. J. Wright, J. R. Thompson, A. J. Balmforth, A. S. Hall, N. J. Samani, C. A. Anderson, T. Ahmad , C. G. Mathew, M. Parkes, J. Satsangi, M. Caulfield, P. B. Munroe, M. Farrall, A. Dominiczak, J. Worthington, W. Thomson, S. Eyre, A. Barton, V. Mooser, C. Francks and J. Marchini: Metaanalysis and imputation refines the association of 15q25 with smoking quantity. Nat Genet, 42(5), 436-40 (2010)
101. C. I. Amos, M. R. Spitz and P. Cinciripini: Chipping away at the genetics of smoking behavior. Nat Genet, 42(5), 366-8 (2010)
102. Yamagiwa Memorial Foundation: Collected papers on artificial production of cancer. Maruzen, Tokyo (1965)
103. E. C. Miller: Some current perspectives on chemical carcinogenesis in humans and experimental animals: Presidential Address. Cancer Res, 38(6), 1479-96 (1978)
104. T. Sugimura: Studies on environmental chemical carcinogenesis in Japan. Science, 233(4761), 312-8 (1986)
105. S. Yoshii, M. Tanaka, Y. Otsuki, T. Fujiyama, H. Kataoka, H. Arai, H. Hanai and H. Sugimura: Involvement of alpha-PAK-interacting exchange factor in the PAK1-c- Jun NH(2)-terminal kinase 1 activation and apoptosis induced by benzo[a]pyrene. Mol Cell Biol, 21(20), 6796-807 (2001)
106. K. Shinmura, M. Iwaizumi, H. Igarashi, K. Nagura, H. Yamada, M. Suzuki, K. Fukasawa and H. Sugimura: Induction of centrosome amplification and chromosome instability in p53-deficient lung cancer cells exposed to benzo[a]pyrene diol epoxide (B[a]PDE). J Pathol, 216(3), 365-74 (2008)
107. B. J. Song, H. V. Gelboin, S. S. Park, G. C. Tsokos and F. K. Friedman: Monoclonal antibody-directed radioimmunoassay detects cytochrome P-450 in human placenta and lymphocytes. Science, 228(4698), 490-2 (1985)
108. R. B. Everson, E. Randerath, R. M. Santella, R. C. Cefalo, T. A. Avitts and K. Randerath: Detection of smoking-related covalent DNA adducts in human placenta. Science, 231(4733), 54-7 (1986)
109. R. A. Kanaly, T. Hanaoka, H. Sugimura, H. Toda, S. Matsui and T. Matsuda: Development of the adductome approach to detect DNA damage in humans. Antioxid Redox Signal, 8(5-6), 993-1001 (2006)
110. P. H. Chou, S. Kageyama, S. Matsuda, K. Kanemoto, Y. Sasada, M. Oka, K. Shinmura, H. Mori, K. Kawai, H. Kasai, H. Sugimura and T. Matsuda: Detection of lipid peroxidation-induced DNA adducts caused by 4-oxo-2(E)- nonenal and 4-oxo-2(E)-hexenal in human autopsy tissues. Chem Res Toxicol, 23(9), 1442-8 (2010)
111. A. F. Gazdar and P. Boffetta: A risky business- identifying susceptibility loci for lung cancer. J Natl Cancer Inst, 102(13), 920-3 (2010)
112. T. Truong, R. J. Hung, C. I. Amos, X. Wu, H. Bickeboller, A. Rosenberger, W. Sauter, T. Illig, H. E. Wichmann, A. Risch, H. Dienemann, R. Kaaks, P. Yang, R. Jiang, J. K. Wiencke, M. Wrensch, H. Hansen, K. T. Kelsey, K. Matsuo, K. Tajima, A. G. Schwartz, A. Wenzlaff, A. Seow, C. Ying, A. Staratschek-Jox, P. Nurnberg, E. Stoelben, J. Wolf, P. Lazarus, J. E. Muscat, C. J. Gallagher, S. Zienolddiny, A. Haugen, H. F. van der Heijden, L. A. Kiemeney, D. Isla, J. I. Mayordomo, T. Rafnar, K. Stefansson, Z. F. Zhang, S. C. Chang, J. H. Kim, Y. C. Hong, E. J. Duell, A. S. Andrew, F. Lejbkowicz, G. Rennert, H. Muller, H. Brenner, L. Le Marchand, S. Benhamou, C. Bouchardy, M. D. Teare, X. Xue, J. McLaughlin, G. Liu, J. D. McKay, P. Brennan and M. R. Spitz: Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. J Natl Cancer Inst, 102(13), 959-71 (2010)
113. R. D. Dowell, O. Ryan, A. Jansen, D. Cheung, S. Agarwala, T. Danford, D. A. Bernstein, P. A. Rolfe, L. E. Heisler, B. Chin, C. Nislow, G. Giaever, P. C. Phillips, G. R. Fink, D. K. Gifford and C. Boone: Genotype to phenotype: a complex problem. Science, 328(5977), 469 (2010)